Frameless image-guided stereotactic body radiation therapy for lung tumors with 4-dimensional computed tomography or 4-dimensional positron emission tomography/ computed tomography

Clinical Lung Cancer

Volumn 12, Issue 3, 2011, Pages 180-186

  Nath, Sameer K ^a   Sandhu, Ajay P ^a   Jensen, Lindsay ^a   Kim, Daniel ^b   Bharne, Anjali ^b   Nobiensky, Polly D ^a   Lawson, Joshua D ^a   Fuster, Mark M ^b   Bazhenova, Lyudmilla ^b   Song, William Y ^a   Mundt, Arno J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Frameless 4 dimensional positron emission tomography computed tomography (4DPET CT); Image guided radiation therapy (IGRT); Lung cancer; Stereotactic body radiation therapy (SBRT)

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL PROTOCOL; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG UPTAKE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; FOUR DIMENSIONAL COMPUTED TOMOGRAPHY; FOUR DIMENSIONAL COMPUTER ASSISTED EMISSION TOMOGRAPHY; FRAMELESS STEREOTACTIC PROCEDURE; HUMAN; LUNG METASTASIS; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT POSITIONING; SAFETY; SIMULATION; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT FAILURE; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; FOUR-DIMENSIONAL COMPUTED TOMOGRAPHY; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOSURGERY;

EID: 79959625879     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2011.03.014     Document Type: Article

References (33)

1. Kavanagh BD, Timmerman RD. Stereotactic Body Radiation Therapy. Philadelphia: Lippincott Williams & Wilkins; 2005.
2. Baumann P, Nyman J, Hoyer M, et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009; 27:3290-6.
3. Lawson JD, Sandhu A, Jiang S, et al. Emerging role of stereotactic radiotherapy (SRT) in the treatment of early stage non-small cell lung cancer. Curr Cancer Ther Rev 2009; 5:281-7.
4. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010; 303:1070-6.
5. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005; 63:1427-31. (Pubitemid 41628038)
6. Chang JY, Balter PA, Dong L, et al. Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008; 72:967-71.
7. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004; 101:1623-31. (Pubitemid 39318910)
8. Rusthoven KE, Kavanagh BD, Burri SH, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2009; 27:1579-84.
9. Rusthoven KE, Kavanagh BD, Candenes H, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009; 27: 1572-8.
10. Wulf J, Hadinger U, Oppitz U, et al. Stereotactic radiotherapy of extracranial targets: CT-simulation and accuracy of treatment in the stereotactic body frame. Radiother Oncol 2000; 57:225-36.
11. Nagata Y, Negoro Y, Aoki T, et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2002; 52:1041-6. (Pubitemid 34219025)
12. Uematsu M, Shioda A, Suda A, et al. Intrafractional tumor position stability during computed tomography (CT)-guided frameless stereotactic radiation therapy for lung or liver cancers with a fusion of CT and linear accelerator (FOCAL) unit. Int J Radiat Oncol Biol Phys 2000; 48:443-8.
13. Shirato H, Shimizu S, Shimizu T, et al. Real-time tumour-tracking radiotherapy. Lancet 1999; 353:1331-2. (Pubitemid 29178792)
14. Mackie TR, Kapatoes J, Ruchala K, et al. Image guidance for precise conformal radiotherapy. Int J Radiat Oncol Biol Phys 2003; 56:89-105. (Pubitemid 36403680)
15. Gibbs IC. Frameless image-guided intracranial and extracranial radiosurgery using the Cyberknife™ robotic system. Cancer Radiother 2006; 10:283-7. (Pubitemid 44486838)
16. Sonke JJ, Rossi M, Wolthaus J, et al. Frameless stereotactic body radiotherapy for lung cancer using four-dimensional cone beam CT guidance. Int J Radiat Oncol Biol Phys 2009; 74:567-74.
17. Bissonnette JP, Purdie TG, Higgins JA, et al. Cone-beam computed tomographic image guidance for lung cancer radiation therapy. Int J Radiat Oncol Biol Phys 2009; 73:927-34.
18. Fuss M, Boda-Heggemann J, Papanikolau N, et al. Image-guidance for stereotactic body radiation therapy. Med Dosim 2007; 32:102-10. (Pubitemid 46654807)
19. Mancosu P, Sghedoni R, Bettinardi V, et al. 4D-PET data sorting into different number of phases: a NEMA IQ phantom study. J Appl Clin Med Phys 2009; 10:220-31.
20. Watkins WT, Li R, Lewis J, et al. Patient specific motion artifacts in 4DCT. Med Phys 2010; 37:2855-61.
21. Song WY, Kamath S, Ozawa S, et al. A dose comparison study between XVI and OBI CBCT systems. Med Phys 2008; 35:480-6. (Pubitemid 351190867)
22. Le QT, Loo BW, Ho A, et al. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol 2006; 1:802-9. (Pubitemid 47181385)
23. Brown WT, Wu X, Fowler JF, et al. Lung metastases treated by CyberKnife image-guided robotic stereotactic radiosurgery at 41 months. South Med J 2008; 101:376-82. (Pubitemid 351507510)
24. Brown WT, Wu X, Fayad F, et al. CyberKnife radiosurgery for stage I lung cancer: results at 36 months. Clin Lung Cancer 2007; 8:488-92. (Pubitemid 47606358)
25. Le QT, Taira A, Budenz S, et al. Mature results from a randomized phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable stage IV head and neck squamous cell carcinomas. Cancer 2006; 106:1940-9. (Pubitemid 43673209)
26. Murphy MJ. Tracking moving organs in real time. Semin Radiat Oncol 2004; 14:91-100. (Pubitemid 38168958)
27. Heron DE, Smith RP, Andrade RS. Advances in image-guided radiation therapy - the role of PET-CT. Med Dosim 2006; 31:3-11.
28. Moreno A, Chambon S, Santhanam AP, et al. Thoracic CT-PET registration using a 3D breathing model. Med Image Comput Comput Assist Interv 2007; 10:626-33.
29. Ponisch F, Richter C, Just U, et al. Attenuation correction of four dimensional (4D) PET using phase-correlated 4D-computed tomography. Phys Med Biol 2008; 53: N259-68. (Pubitemid 352020052)
30. Nehmeh SA, Erdi YE, Pan T, et al. Four-dimensional (4D) PET/CT imaging of the thorax. Med Phys 2004; 31:3179-86. (Pubitemid 40064969)
31. Aoki M, Abe Y, Kondo H, et al. Clinical outcome of stereotactic body radiotherapy of 54 Gy in nine fractions for patients with localized lung tumor using a custommade immobilization system. Radiat Med 2007; 25:289-94. (Pubitemid 351928044)
32. Norihisa Y, Nagata Y, Takayama K, et al. Stereotactic body radiotherapy for oligometastatic lung tumors. Int J Radiat Oncol Biol Phys 2008; 72:398-403.
33. Hamamoto Y, Kataoka M, Yamashita M, et al. Local control of metastatic lung tumors treated with SBRT of 48 Gy in four fractions: in comparison with primary lung cancer. Jpn J Clin Oncol 2010; 40:125-9.